Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

Published:2020-06-25 Issue:11 Volume:61 Page:2714-2721
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Song Ga-Young¹,Jung Sung-Hoon¹,Lee Je-Jung¹,Kim Jin Seok²,Min Chang-Ki³,Kim Kihyun⁴,Choi Yunsuk⁵,Eom Hyeon-Seok⁶,Joo Young Don⁷,Kim Sung-Hyun⁸,Kwak Jae-Yong⁹,Kang Hye Jin¹⁰,Lee Jae Hoon¹¹,Lee Ho Sup¹²,Mun Yeung-Chul¹³,Moon Joon Ho¹⁴,Sohn Sang Kyun¹⁴,Park Seong Kyu¹⁵,Park Yong¹⁶,Shin Ho-Jin¹⁷,Yoon Sung-Soo¹⁸

Affiliation:

1. Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea

2. Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

3. Seoul St. Mary’s Hospital, Catholic University of Korea, Seoul, Republic of Korea

4. Samsung Medical Center, Seoul, Republic of Korea

5. Ulsan University Hospital, Ulsan, Republic of Korea

6. National Cancer Center, Goyang-si, Republic of Korea

7. Inje University Busan Paik Hospital, Busan, Republic of Korea

8. Dong-A Medical Center, Busan, Republic of Korea

9. Chonbuk National University Medical School, Jeonju, Republic of Korea

10. Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea

11. Gachon University Gil Hospital, Incheon, Republic of Korea

12. Kosin University Gospel Hospital, Busan, Republic of Korea

13. Ewha Woman’s University School of Medicine, Seoul, Republic of Korea

14. Kyungpook National University Hospital, Daegu, Republic of Korea

15. Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea

16. Korea University College of Medicine, Seoul, Republic of Korea

17. Pusan National University Hospital, Busan, Republic of Korea

18. Seoul National University Hospital, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1783448

Reference23 articles.

1. Multiple myeloma: Autologous stem cell transplantation versus conventional chemotherapy—A retrospective age and stage matched analysis

2. High-dose melphalan for multiple myeloma: long-term follow-up data.

3. Myeloablative Treatments for Multiple Myeloma: Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple Myeloma

4. Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)

5. International Staging System for Multiple Myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan, melphalan and carfilzomib high‐dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma;British Journal of Haematology;2024-01-04

2. Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study);Frontiers in Oncology;2022-08-30

3. Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis;Cancer Cell International;2021-11-10

4. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea;The Korean Journal of Internal Medicine;2021-11-01

5. Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma;Therapeutic Advances in Hematology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3